COMMUNIQUÉS West-GlobeNewswire

Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements
01/07/2024
MINNEAPOLIS, July 01, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced it has filed its Form 10-Q for the quarter ended March, 31, 2024 and in doing so has regained [...]
Inside information: Orion upgrades full-year outlook for 2024
01/07/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 1 JULY 2024 at 15:15 EEST Inside information: Orion upgrades full-year outlook for 2024 Orion Corporation upgrades the full-year outlook for 2024 both for [...]
Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
01/07/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 1 JULY 2024 at 15:15 EEST Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an [...]
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
01/07/2024
$8M grant supports ongoing Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia SOUTH SAN FRANCISCO, Calif., July 01, 2024 (GLOBE [...]
Kraig Biocraft Laboratories Expands Facilities to Support Spider Silk Production Growth
01/07/2024
ANN ARBOR, Mich., July 01, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has achieved full capacity at its current production location [...]
NeuroStar® Launches Better Me Provider Program Nationwide
01/07/2024
The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry MALVERN, Pa., July 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a [...]
G1 Therapeutics Added to the Russell 2000® and 3000® Indexes
01/07/2024
RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced that the Company has been added to the broad-market Russell [...]
Spectral AI Joins Russell Microcap® Index
01/07/2024
DALLAS, July 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327
01/07/2024
Results demonstrate efficacy on bacterial growth in participants injected with RECCE ® 327 (R327) at the highest tested dose of 4,000mg No serious adverse events and clinically significant changes observed, reinforcing [...]
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
01/07/2024
The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the target pharmacokinetic [...]
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum
01/07/2024
SAN DIEGO, CA and TIACANG, China, July 01, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect or the Company), a U.S.-headquartered, global clinical-stage biopharmaceutical company [...]
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program
01/07/2024
Defense Threat Reduction Agency (DTRA) contract is expected to advance development of Tonix’s broad-spectrum oral antiviral program TNX-4200 for medical countermeasures CHATHAM, N.J., July 01, 2024 (GLOBE NEWSWIRE) -- [...]
Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)
01/07/2024
– Third RMAT designation by FDA for ATEV – – RMAT will expedite development of ATEV in PAD – DURHAM, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company [...]
Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
01/07/2024
CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly [...]
Halo Dental Technologies Wins Prestigious Red Dot Award for Design Concept 2024 with Innovative Halo Digital Mirror
01/07/2024
Revolutionizing Patient Care and Clinical Workflows with Cutting-Edge Dental Technology MONTREAL, July 01, 2024 (GLOBE NEWSWIRE) -- Halo Dental Technologies, which is pushing dental practice innovation through the [...]
Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer
01/07/2024
UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length [...]
Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
01/07/2024
Drug-device combination leverages Biora’s NaviCap ™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis BT-600 was well tolerated and met all trial objectives, [...]
ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
28/06/2024
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Runway Growth Capital LLC is a leading U.S.-based specialty finance lender [...]
LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders
28/06/2024
BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its [...]

Pages